Cursor Talk to Figma MCP vs LynxKite
A side-by-side look at pricing, capabilities, pros, cons, and our editorial scores.
Cursor Talk to Figma MCP Agents | LynxKite Agents | |
|---|---|---|
| Tagline | Open-source MCP bridge that lets Cursor and Claude Code read and edit Figma files directly from the editor. | No-code AI orchestration platform built for graph-native pipelines in drug discovery and enterprise analytics. |
| Category | Agents | Agents |
| Pricing | Free· Free, open-source (MIT) | Enterprise· Contact sales; no public pricing |
| Model | Multi-model (Cursor / Claude Code via MCP) | Multi-model (LLM agents + GNNs + NVIDIA BioNeMo) |
| Editorial score | 7.0 / 10 | 6.9 / 10 |
| Use cases | figma-automationdesign-to-codebulk-text-editscomponent-overridesprototype-wiring | drug-discoverygraph-neural-networksknowledge-graphsai-workflow-orchestrationenterprise-ml-pipelines |
| Pros |
|
|
| Cons |
|
|
| Website | www.figma.com | lynxkite.com |
Pick Cursor Talk to Figma MCP if
- ✅ Genuine two-way Figma control from Cursor or Claude Code via MCP
- ✅ Open-source, MIT-licensed, fully local with no SaaS dependency
- ✅ Broad tool surface: text, components, auto-layout, prototypes, exports
- ✅ Active project with strong GitHub traction (~6.9k stars)
Pick LynxKite if
- ✅ Graph-native: first-class GNNs and knowledge graphs, not bolted on
- ✅ GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations
- ✅ No-code workflow builder usable by non-engineer domain experts
- ✅ Pre-built pharma pipelines shorten time to first model